Biggest News Aggregation in the World
📰 Global Data News

Page 102 - Global Data News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Global Data. Real-time updates on events, politics, business and more.

Z : (Update) Final Report Received from the Special Advisory Committee on Global Data Governance Regarding LINE's Handling of Data, Etc.

October 18, 2021 To whom it may concern Z Holdings Corporation Kentaro Kawabe President and Representative Director,... | October 18, 2021
Advisory Committee On Advisory Committee On Global Data Z Holdings Corporation Z Holdings Corporation Kentaro Kawabe Advisory Committee On Global Data Governance Z Holdings Group

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cboe Appoints Bo Chung To Senior Vice President, Global Sales And Index Licensing, Expanding Data And Access Solutions Leadership Team

<ul>
<li><hl2>Bo Chung joins Cboe as Senior Vice President, Global Sales and Index Licensing</hl2></li>
<li><hl2>Michael Hollingsworth promoted to Vice President, Global Head of Data and Analytics</hl2></li>
<li><hl2>Geralyn Endo promoted to Vice President, Global Data and Access Solutions Client Engagement</hl2></li>
</ul>
Bo Chung Geralyn Endo Michael Hollingsworth Catherine Clay Sp Dow Jones Access Solutions Client Engagement

Investegate |Active Biotech Announcements | Active Biotech: Active Biotech: Tasquinimod clinical  development in multiple myeloma advances into combination therapy following completion of the initial phase of the ongoing trial in the US

Investegate announcements from Active Biotech, Active Biotech: Tasquinimod clinical  development in multiple myeloma advances into combination therapy following completion of the initial phase of the ongoing trial in the US
Hans Kolam Dan Vogl International Myeloma Working Group University Of Pennsylvania Abramson Cancer Center Active Biotech

Active Biotech: Tasquinimod clinical development in multiple myeloma advances into combination therapy following completion of the initial phase of the ongoing trial in the US

Lund Sweden, October 3, 2021 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announces that the ongoing trial of tasquinimod in multiple myeloma has reached an important milestone. Ten patients have been
Hans Kolam Dan Vogl International Myeloma Working Group University Of Pennsylvania Abramson Cancer Center Lund Sweden

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science